Abbott Laboratories (ABT)
116.67
+0.03
(+0.03%)
USD |
NYSE |
Aug 24, 16:00
116.64
-0.03
(-0.03%)
After-Hours: 19:27
Abbott Laboratories Debt to Equity Ratio : 0.638 for June 30, 2026
Debt to Equity Ratio Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.638 |
| March 31, 2026 | 0.654 |
| December 31, 2025 | 0.2712 |
| September 30, 2025 | 0.254 |
| June 30, 2025 | 0.2657 |
| March 31, 2025 | 0.2713 |
| December 31, 2024 | 0.3205 |
| September 30, 2024 | 0.3764 |
| June 30, 2024 | 0.3752 |
| March 31, 2024 | 0.3758 |
| December 31, 2023 | 0.4112 |
| September 30, 2023 | 0.4143 |
| June 30, 2023 | 0.4532 |
| March 31, 2023 | 0.4566 |
| December 31, 2022 | 0.4892 |
| September 30, 2022 | 0.4601 |
| June 30, 2022 | 0.4593 |
| March 31, 2022 | 0.4828 |
| December 31, 2021 | 0.5377 |
| September 30, 2021 | 0.5345 |
| June 30, 2021 | 0.5474 |
| March 31, 2021 | 0.5496 |
| December 31, 2020 | 0.6067 |
| September 30, 2020 | 0.5914 |
| June 30, 2020 | 0.6436 |
| Date | Value |
|---|---|
| March 31, 2020 | 0.6047 |
| December 31, 2019 | 0.6144 |
| September 30, 2019 | 0.6286 |
| June 30, 2019 | 0.6333 |
| March 31, 2019 | 0.6437 |
| December 31, 2018 | 0.641 |
| September 30, 2018 | 0.7672 |
| June 30, 2018 | 0.676 |
| March 31, 2018 | 0.6972 |
| December 31, 2017 | 0.9038 |
| September 30, 2017 | 0.75 |
| June 30, 2017 | 0.7604 |
| March 31, 2017 | 0.7644 |
| December 31, 2016 | 1.072 |
| September 30, 2016 | 0.4096 |
| June 30, 2016 | 0.4311 |
| March 31, 2016 | 0.4145 |
| December 31, 2015 | 0.4244 |
| September 30, 2015 | 0.3958 |
| June 30, 2015 | 0.3808 |
| March 31, 2015 | 0.407 |
| December 31, 2014 | 0.3637 |
| September 30, 2014 | 0.3627 |
| June 30, 2014 | 0.312 |
| March 31, 2014 | 0.332 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Debt to Equity Ratio Benchmarks
| Becton, Dickinson & Co. | 0.6884 |
| Boston Scientific Corp. | 0.5064 |
| DexCom, Inc. | 0.5335 |
| Insulet Corp. | 0.6669 |
| Intuitive Surgical, Inc. | 0.00 |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 109.22B |
| Total Liabilities (Quarterly) | 57.45B |
| Shareholders Equity (Quarterly) | 51.11B |
| Current Ratio | 1.376 |
| Net Debt Paydown Yield | -2.47% |